Shin Nippon Biomedical Laboratories, Ltd. (2395.T) JPX

1,588.00

+21(+1.34%)

Updated at October 20 10:37AM

Currency In JPY

Valuation

Market Cap59.58B
Enterprise Value82.02B
P/E Ratio12.88
PEG Ratio4.59
Price/Sales Ratio1.96
Price/Book Ratio1.84
Enterprise/Revenue2.71
Enterprise/EBITDA10.18

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.15
Operating Margin0.08

Management Effectiveness

Return On Assets0.06
Return On Equity0.13

Income Statement

Revenue32.41B
Revenue/Share800.88
Gross Profit16.57B
EBITDA8.83B
Net Income4.92B
Diluted EPS118.3

Balance Sheet

Total Cash11.57B
Total Cash/Share277.94
Total Debt36.58B
Total Debt/Equity1.03
Current Ratio1.14
Book Value Per Share862.28

Price History

52-Week Change21.95
52-Week High1,897
52-Week Low1,142
Moving Average 50 Days1,648.46
Moving Average 200 Days1,505.79

Statistics

Average Volume232,588
Shares Outstanding41.63M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield3.19
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 27, 2005